article thumbnail

Why SAP ERP Makes Sense for Pharmaceutical Manufacturing

Navigator SAP

Legacy software systems no longer make sense for life sciences businesses, especially those in Pharmaceutical manufacturing. The problem is that complexity, regulation, and competition have changed how pharmaceutical and life sciences firms must do business. Other benefits include: 1.

article thumbnail

Johnson & Johnson Sales Rise 8.3 Pct Amid Consumer Health, Pharmaceutical Growth

PYMNTS

26) as part of its financial results that reported sales grew by 8.3 percent from Q4 2019 to Q4 2020, as consumer health and pharmaceutical sales rose while medical devices worldwide operational sales fell amid the pandemic. The company reported that consumer health worldwide operational sales grew 3.1 billion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Giant Sees Largest-Ever Bond Sale

Global Finance

Global Finance Magazine - Pfizer’s eight tranches of notes, priced from $3 billion to $6 billion each, will mature between 2025 and 2063.&

article thumbnail

Merck, Eli Lilly Covid-19 Treatments Power Quarterly Sales Gains

CFO News Room

Merck’s newly authorized molnupiravir treatment logged sales of $952 million in the fourth quarter, the first period when the drug contributed revenue. Meanwhile, sales of Covid-19 antibodies for Lilly grew by 22% year over year to $1.06 Regeneron Pharmaceuticals Inc. Overall, Merck’s sales for October through December were $13.52

Sales 130
article thumbnail

Alibaba Raises $1.3B For Push Into eCommerce Pharmaceutical Business

PYMNTS

billion it raised in a secondary offering on the Hong Kong stock exchange to expand its eCommerce pharmaceutical business as it rides a wave of growth amid the coronavirus. The move comes roughly six months after Alibaba launched a sales platform for medical supplies needed to fight the coronavirus.

article thumbnail

Netflix, Alphabet, Nordstrom, PagerDuty, more

CFO News Room

” Eli Lilly — Shares of the pharmaceutical company slumped more than 1% in premarket after the U.S. Regeneron Pharmaceuticals — The pharmaceutical giant gained 1% in the premarket after being upgraded to overweight from neutral by JPMorgan. The firm also announced that co-CEO Reed Hastings would step down from the role.

article thumbnail

Cipla founding family’s stake sale in jeopardy over $13 billion valuation target

CFO News

Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. While no final decision has been made, the family may revise the asking price or decide against the sale. Cipla's sales have been bolstered by Covid-19 treatments, including the license to produce remdesivir.